Abstract
Hypertension is a major comorbidity in patients with heart failure with preserved ejection fraction (HFpEF), which remains an increasing global challenge. Cardiac remodelling and dysfunction as well as altered calcium (Ca2+) homeostasis are all characteristics of this disease1,2. However, existing models and evidence on the mechanisms driving this form of cardiomyopathy remain contradictory.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 4 Sept 2023 |
Event | British Society for Cardiovascular research Autumn meeting 2023 - University of Oxford Duration: 4 Sept 2023 → 5 Sept 2023 |
Conference
Conference | British Society for Cardiovascular research Autumn meeting 2023 |
---|---|
Period | 4/09/23 → 5/09/23 |
Keywords
- hypertension
- angiotensin
- in vivo models